leading semaglutide law office FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Mass Tort Litigation for Ozempic

Future studies may apply a Mendelian randomization approach to elucidate the association between functional IGF-1R polymorphisms and BrCa risk

Insulin, sulfonylureas, and certain oral drugs taken at the same time are the categories most often discussed, while everyday habits like caffeine or alcohol may add to digestive discomfort rather than cause a true pharmacological conflict

Metabolic syndrome and heart transplantation: an underestimated risk factor

Constipation linked to GLP-1 drugs can be uncomfortable and may impact a person's quality of life

Long-term gastrointestinal outcomes in patients on teduglutide: a propensity-matched analysis